Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders.

Clinical trial NCT03344328 · COMPLETED

Trial details

NCT number: NCT03344328
Sponsor: University Hospital, Clermont-Ferrand
Status: COMPLETED
Study type: OBSERVATIONAL

Chemotherapy Induced Peripheral Neuropathy Multiple Myeloma

Start date: 2019-01-15
Primary completion: 2019-12-31
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.